Integrated Magnetic Systems Ltd (IMSL), a biotechnology company based in Dundee, Scotland, is expanding into new premises, which it will convert into a protein production facility.
The expansion is being partly funded by a Scottish Enterprise Regional Selective Assistance (RSA) grant of £59,000, in addition to the company’s own investment of £168,000.
ISML will create four new jobs with the move.
IMSL’s chief executive Eddie Blair said: ‘This grant provides the assistance we need to build a production facility that enables us to supply large quantities of magnetic proteins to our customers around the world. Without this aid, IMSL would struggle to meet demand, thus missing opportunities, disappointing customers and risking failure. Instead, in a few months’ time, IMSL will enter the lucrative market of recombinant protein production, offering a unique and useful biotechnology product, invented in Scotland and staying in Scotland.’
‘We really needed to invest in a proper Production Facility,’ added Dr Prabs Dehal, IMSL’s chief scientific officer. ‘Our small-scale, bench-top production runs were enough to prove the technology works, and good enough to get the attention of several global biotech suppliers, but it would have been impossible for us to make magnetic proteins at the required larger-scales in our current lab.’